PTE News and Press, PolarityTE Inc. From 05/10/21

Reports Peer-Reviewed Publication of Interim Results from Diabetic Foot Ulcer Trial in International Wound Journal PolarityTE, Inc. (Nasdaq: PTE) today announced preliminary topline data demonstrating that a multi-center randomized controlled trial evaluating treatment o...

PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the quarter ended March 31, 2021 by press release on Thursday, May 13, 2021 at approximately 4:00 p.m. Eastern Time. In addition, the Company will host a conference call and webcast with Q&A on Ma...

Like all microcap biotechs, PolarityTE is a very risky bet. But they have a product with the potential to revolutionize wound care. This is a giant addressable market. I go over the promise, the risks, recent trials, and future plans. For further details see: PolarityTE:...

The following slide deck was published by PolarityTE, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: PolarityTE, Inc. 2020 Q4 - Results - Earnings Call Presentation

PolarityTE, Inc. (PTE) Q4 2020 Earnings Conference Call March 30, 2021 08:00 a.m. ET Company Representatives David Seaburg - Chief Executive Officer Richard Hague - President, Chief Operating Officer Jake Patterson - Interim Chief Financial Officer Rich Haerle - Vice President of Investor Rel...

PolarityTE (PTE) share up more than 5% premarket after the company posts fourth-quarter revenue that beat Wall Street estimates, helped by the strength in the company's SkinTE business.Total revenue in the fourth quarter more than doubled to $3.59M compared to the same period l...

PolarityTE (PTE): Q4 Operational cash burn of $4.82MRevenue of $3.59M (+144.2% Y/Y) beats by $0.69M.Shares -1.63% PM.Press Release For further details see: PolarityTE beats on revenue

Fourth Quarter Revenues of $3.59 million and Full Year 2020 Revenues of $10.13 million PolarityTE to host conference call and webcast today, March 30, 2021 at 8:00 a.m. ET PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing regenerative tissue pro...

Support.com (SPRT) +271% as Greenidge Generation Holdings to go public via merger with the company.Seneca Biopharma (SNCA) +30%.Cemtrex (CETX) +21%.Marker Therapeutics (MRKR) +19%.Acer Therapeutics (ACER) +19%.Kansas City Southern (KSU) +17% as Canadian Pacific to buy the company fo...

PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the year ended December 31, 2020 by press release on Tuesday, March 30, 2021 at approximately 7:00 a.m. Eastern Time. In addition, the Company will host a conference call and webcast with Q&A on M...